Analysis of Business Deal: Collegium Pharma acquired of U.S. Rights to Nucynta Franchise for $375M
Collegium Pharmaceutical, a specialty pharmaceutical company, has entered into a definitive agreement to acquire the U.S. rights to the Nucynta Franchise from... Read More